Table 4.
Placebo | 20 g Whey | 40 g Whey | |||||
---|---|---|---|---|---|---|---|
miR | 2 h | 4 h | 2 h | 4 h | 2 h | 4 h | p-value |
miR-23a | 0.92 ± 0.65 | 0.88 ± 0.48 | 1.49 ± 1.29 | 1.15 ± 0.58 | 1.23 ± 1.22 | 1.25 ± 1.16 | 0.858 |
miR-23b | 0.95 ± 0.88 | 0.78 ± 0.40 | 1.11 ± 0.56 | 1.05 ± 0.85 | 1.25 ± 0.79 | 1.27 ± 0.71 | 0.915 |
miR-30b | 1.20 ± 0.57 | 1.14 ± 0.54 | 1.16 ± 0.66 | 1.32 ± 1.03 | 1.05 ± 0.79 | 1.07 ± 0.51 | 0.968 |
miR-100 | 1.13 ± 0.71 | 1.15 ± 0.85 | 0.76 ± 0.11 | 1.20 ± 1.48 | 0.65 ± 0.23 | 1.33 ± 0.85 | 0.725 |
miR-126 | 1.29 ± 0.76 | 1.10 ± 0.88 | 1.40 ± 0.61 | 1.38 ± 0.98 | 1.17 ± 0.65 | 1.54 ± 0.71 | 0.762 |
miR-133a | 1.55 ± 1.24 | 1.60 ± 1.84 | 1.90 ± 1.03 | 2.16 ± 2.14 | 1.65 ± 2.52 | 2.15 ± 1.64 | 0.979 |
miR-145 | 1.10 ± 0.65 | 0.95 ± 0.65 | 0.98 ± 0.48 | 1.10 ± 0.93 | 1.12 ± 0.71 | 1.32 ± 0.88 | 0.899 |
miR-206 | 1.39 ± 1.30 | 0.99 ± 0.68 | 1.48 ± 0.82 | 1.42 ± 0.85 | 1.14 ± 0.45 | 0.93 ± 0.57 | 0.829 |
miR-208a | 1.46 ± 1.27 | 2.07 ± 2.12 | 1.23 ± 1.24 | 1.56 ± 2.01 | 1.17 ± 0.65 | 1.50 ± 0.82 | 0.969 |
miR-486 | 1.01 ± 0.34 | 1.35 ± 1.19 | 1.30 ± 0.85 | 1.32 ± 0.95 | 1.13 ± 0.48 | 1.26 ± 0.83 | 0.966 |
Values presented as means ± SD, n = 8 placebo, n = 7, 20 g whey, and n = 8, 40 g whey. p-values represent group by time interactions from two-way repeated measures ANOVA.